This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vision Tech Bio Pty. Ltd.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations in Colorectal Cancer Detection by Bruce Tabor
Introduction
Bruce Tabor, an innovative inventor based in Stanhope Gardens, Australia, has made significant contributions to the field of medical diagnostics. With a commitment to improving patient outcomes, he focuses on developing methods for the early detection of colorectal cancer, emphasizing the importance of timely diagnosis in managing this prevalent disease.
Latest Patents
Bruce Tabor holds a patent for a groundbreaking method designed to diagnose or detect colorectal cancer. This patent outlines a procedure that involves determining the presence and/or level of specific biomarkers, including IL-8, IGFBP2, MAC2BP, M2PK, IL-13, DKK-3, EpCam, MIP1β, TGFβ1, and TIMP-1. Furthermore, the invention encompasses diagnostic kits that contain reagents for measuring these biomarkers, providing healthcare professionals with essential tools for diagnosing colorectal cancer effectively.
Career Highlights
Tabor's work is currently associated with Vision Tech Bio Pty. Ltd., a company focused on advancing biotechnological solutions for medical diagnostics. His dedication to researching and developing innovative diagnostic methods reflects a broader commitment to enhancing healthcare technologies that benefit patients and practitioners alike.
Collaborations
Throughout his career, Tabor has collaborated with esteemed colleagues, including Leah Jane Cosgrove and Antony Wilks Burgess. These partnerships foster a creative environment that promotes innovation and the successful realization of new diagnostic methods, enriching the research and development efforts within the biomedical field.
Conclusion
Bruce Tabor stands out as a notable inventor in the realm of colorectal cancer diagnostics. His pioneering patent demonstrates the potential impact of targeted biomarker detection in improving patient care. As he continues to work with Vision Tech Bio Pty. Ltd. and collaborate with fellow researchers, Tabor's contributions to medical innovation are sure to leave a lasting legacy in the fight against colorectal cancer.